The world today is finding itself engrossing in a health crisis. The Covid-19 outbreak is creating a disturbance in the lives of everyone around the globe. At this point, it is difficult to think about the cannabis industry and reform movement, the impact of coronavirus is not only affecting the economy and the society but also the cannabis industry. As per speculations, the effects are likely to get worse in the coming times if the outbreak isn’t kept under control.
Tilray, a leading name in the cannabis industry showed their concerns regarding the effects of the Covid-19 outbreak. Tilray is a leader in cannabis research, cultivation, processing, and distribution.
Amidst the lockdown, Tilray ensures that its medical cannabis products will be available and production for them will also continue. Despite the ongoing pandemic, Tilray has ensured patients about its highest quality products.
Tilray medical cannabis products remain available & in production for our global patients. While the pandemic may mean limited or slower access in some areas, please know that we are doing everything we can to ensure patients have access to our high quality products.
— Tilray (@tilray) March 23, 2020
Talking about the same in a series of tweets, Tilray looks to prioritize the health, safety, and well-being of their team.
On the lines of talking about their concern for their workforce, Tilry has paused all non-essential company travel that includes domestic and international flights, conference meetings and attendance. As a precautionary measure, the employees are encouraged to work from home.
We will continue to prioritize the health, safety and well-being of our workforce and the people in the communities where we operate.
— Tilray (@tilray) March 13, 2020
Tilray produces a wide range of medical cannabis which is available in two primary forms; extracts and dried flowers. Each of them can be consumed through a variety of methods. Tilray is the first company that could legally export medical cannabis from North America and New Zealand. As of now, Tilray is one of the leading providers of medical cannabis in Australia and New Zealand for research purposes.
